Case Report
BibTex RIS Cite
Year 2022, Volume: 5 Issue: 1, 104 - 106, 01.01.2022
https://doi.org/10.19127/bshealthscience.930247

Abstract

References

  • Adelman M, Albelda SM, Gottlieb J, Haponik EF. 1984. Diagnostic utility of pleural fluid eosinophilia. The American J Med, 77(5): 915-920.
  • André S, Drowart A, De Bels D. 2005. Lymphocytic pleural effusion associated with valproic acid. European J Inter Med, 16(7): 535.
  • Antony VB. 1998. Drug-induced pleural disease. Clinics in chest Med, 19(2): 331-340.
  • Bally C, Martin C, Kraoua S, Kanaan R, Lacronique J, Dusser D, Burgel P. 2011. Eosinophilic pleural effusion related to taking valproic acid. Revue de Pneum Clin, 67(6): 363.
  • Heidecker J, Kaplan A, Sahn SA. 2006. Pleural fluid and peripheral eosinophilia from hemothorax: Hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. The American J Med Sci, 332(3): 148-152.
  • Huggins JT, Sahn SA. 2004. Drug-induced pleural disease. Clinics in Chest Med, 25(1): 141-153.
  • Kalomenidis I, Light RW. 2003. Eosinophilic pleural effusions. Current Opin Pulmon Med, 9(4): 254-260.
  • Kaufman J, O'Shaughnessy IM. 1995. Eosinophilic pleural effusion associated with valproic acid administration. Southern Med J, 88(8): 881-882.
  • Krenke R, Nasilowski J, Korczynski P, Gorska K, Przybylowski T, Chazan R, Light RW. 2009. Incidence and aetiology of eosinophilic pleural effusion. European Respir J, 34(5): 1111-1117.
  • Rubins JB, Rubins HB. 1996. Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest, 110(5): 1271-1274.

Eosinophilic Pleuropericardial Effusion due to Valproic Acid

Year 2022, Volume: 5 Issue: 1, 104 - 106, 01.01.2022
https://doi.org/10.19127/bshealthscience.930247

Abstract

Valproic acid is widely used in the treatment of many diseases. It has common side effects such as nausea, vomiting, diarrhea, dizziness, tremor, hair loss, thrombocytopenia. Valproic acid can rarely cause eosinophilic pleuropericardial effusion. Case report; a 31-year-old male patient who had been using valproic acid since childhood due to epilepsy presented with respiratory distress. Eosinophilic pleuropericardial effusion was detected in the examinations performed in the patient with progressive respiratory distress. After excluding other etiological causes, this condition is assumed to be related to valproic acid. Drug changes were made. The end of six months, was observed to be completely cured. Conclusion: This adverse is generally thought to result from drug hypersensitivity reaction. But it is seen that it is an important factor in drug dosage.

References

  • Adelman M, Albelda SM, Gottlieb J, Haponik EF. 1984. Diagnostic utility of pleural fluid eosinophilia. The American J Med, 77(5): 915-920.
  • André S, Drowart A, De Bels D. 2005. Lymphocytic pleural effusion associated with valproic acid. European J Inter Med, 16(7): 535.
  • Antony VB. 1998. Drug-induced pleural disease. Clinics in chest Med, 19(2): 331-340.
  • Bally C, Martin C, Kraoua S, Kanaan R, Lacronique J, Dusser D, Burgel P. 2011. Eosinophilic pleural effusion related to taking valproic acid. Revue de Pneum Clin, 67(6): 363.
  • Heidecker J, Kaplan A, Sahn SA. 2006. Pleural fluid and peripheral eosinophilia from hemothorax: Hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. The American J Med Sci, 332(3): 148-152.
  • Huggins JT, Sahn SA. 2004. Drug-induced pleural disease. Clinics in Chest Med, 25(1): 141-153.
  • Kalomenidis I, Light RW. 2003. Eosinophilic pleural effusions. Current Opin Pulmon Med, 9(4): 254-260.
  • Kaufman J, O'Shaughnessy IM. 1995. Eosinophilic pleural effusion associated with valproic acid administration. Southern Med J, 88(8): 881-882.
  • Krenke R, Nasilowski J, Korczynski P, Gorska K, Przybylowski T, Chazan R, Light RW. 2009. Incidence and aetiology of eosinophilic pleural effusion. European Respir J, 34(5): 1111-1117.
  • Rubins JB, Rubins HB. 1996. Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest, 110(5): 1271-1274.
There are 10 citations in total.

Details

Primary Language English
Subjects ​Internal Diseases
Journal Section Case Report
Authors

Fatma Şimşek 0000-0003-1662-5534

Nazım Kızıldağ 0000-0003-1655-5695

Publication Date January 1, 2022
Submission Date April 30, 2021
Acceptance Date December 1, 2021
Published in Issue Year 2022 Volume: 5 Issue: 1

Cite

APA Şimşek, F., & Kızıldağ, N. (2022). Eosinophilic Pleuropericardial Effusion due to Valproic Acid. Black Sea Journal of Health Science, 5(1), 104-106. https://doi.org/10.19127/bshealthscience.930247
AMA Şimşek F, Kızıldağ N. Eosinophilic Pleuropericardial Effusion due to Valproic Acid. BSJ Health Sci. January 2022;5(1):104-106. doi:10.19127/bshealthscience.930247
Chicago Şimşek, Fatma, and Nazım Kızıldağ. “Eosinophilic Pleuropericardial Effusion Due to Valproic Acid”. Black Sea Journal of Health Science 5, no. 1 (January 2022): 104-6. https://doi.org/10.19127/bshealthscience.930247.
EndNote Şimşek F, Kızıldağ N (January 1, 2022) Eosinophilic Pleuropericardial Effusion due to Valproic Acid. Black Sea Journal of Health Science 5 1 104–106.
IEEE F. Şimşek and N. Kızıldağ, “Eosinophilic Pleuropericardial Effusion due to Valproic Acid”, BSJ Health Sci., vol. 5, no. 1, pp. 104–106, 2022, doi: 10.19127/bshealthscience.930247.
ISNAD Şimşek, Fatma - Kızıldağ, Nazım. “Eosinophilic Pleuropericardial Effusion Due to Valproic Acid”. Black Sea Journal of Health Science 5/1 (January 2022), 104-106. https://doi.org/10.19127/bshealthscience.930247.
JAMA Şimşek F, Kızıldağ N. Eosinophilic Pleuropericardial Effusion due to Valproic Acid. BSJ Health Sci. 2022;5:104–106.
MLA Şimşek, Fatma and Nazım Kızıldağ. “Eosinophilic Pleuropericardial Effusion Due to Valproic Acid”. Black Sea Journal of Health Science, vol. 5, no. 1, 2022, pp. 104-6, doi:10.19127/bshealthscience.930247.
Vancouver Şimşek F, Kızıldağ N. Eosinophilic Pleuropericardial Effusion due to Valproic Acid. BSJ Health Sci. 2022;5(1):104-6.